RINO, Y., YUKAWA, N., SATO, T., OSHIMA, T., TANABE, H., YAMAMOTO, Y., . . . MASUDA, M. (2013). Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer. D.A. Spandidos.
Dyfyniad Arddull ChicagoRINO, YASUSHI, et al. Phase II Study On the Combination of Irinotecan Plus Cisplatin As a Second-line Therapy in Patients With Advanced or Recurrent Gastric Cancer. D.A. Spandidos, 2013.
Dyfyniad MLARINO, YASUSHI, et al. Phase II Study On the Combination of Irinotecan Plus Cisplatin As a Second-line Therapy in Patients With Advanced or Recurrent Gastric Cancer. D.A. Spandidos, 2013.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.